Giving sales the right insights, at the right moment, to do what they do best.
Providing marketing with visibility and control to manage campaigns that physicians will value.
Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision. With brand strategy as a starting point, Aktana analyzes market data, channel activity and HCP preference to provide life science companies with the insights, clarity and guidance to deliver the right information at the right time to physicians and their patients. In fact, nearly half of the world's top-20 pharmaceutical companies rely on Aktana to put complex data into context, coordinate channel activity and improve sales effectiveness by up to 30 percent.
Artificial intelligence (AI) has already proved to be useful when it comes to life sciences R&D, starting to fruitfully aid in plumbing the vast depths of discovery, clinical, and real-world data. However, the benefits of AI are now making themselves known on the business side of the life sciences industry, enabling commercial teams to better understand and address the needs of the healthcare providers and patients they serve. In 2019, the following trends will help to define how AI can become better integrated into the commercial side of life sciences businesses.